Skip to main content

Part of Cancer staging guidance sheets

Wilms tumour of the kidney

Current Chapter

Current chapter – Wilms tumour of the kidney


Introduction

This is the data sheet for TNM 8th edition staging of wilms tumour of the kidney.


Stage groupings

Wilms tumour stage

Stage  Description

Stage I

a) The tumour is limited to kidney or surrounded with a fibrous pseudocapsule if outside of the normal contours of the kidney. The renal capsule or pseudocapsule may be infiltrated with the tumour but it does not reach the outer surface, and it is completely resected (resection margins ‘clear’)

b) The tumour may be protruding (‘bulging’) into the pelvic system and ‘dipping’ into the ureter (but it is not infiltrating their walls)

c) The vessels of the renal sinus are not involved

d) Intra renal vessel involvement may be present

Fine needle aspiration or percutaneous core needle biopsy (‘tru-cut’) does not upstage the tumour.

Stage II

a) The tumour extends beyond kidney or penetrates through the renal capsule and/or fibrous pseudocapsule into peri-renal fat but is completely resected (resection margins ‘clear’)

b) Tumour infiltrates the renal sinus and/or invades blood and lymphatic vessels outside the renal parenchyma but it is completely resected

c) Tumour infiltrates adjacent organs or vena cava but is completely resected

Stage III

a) Incomplete excision of the tumour which extends beyond resection margins (gross or microscopic tumour remains post-operatively)

b) Any abdominal lymph nodes are involved

c) Tumour rupture before or intra-operatively (irrespective of other criteria for staging)

d) The tumour has penetrated through the peritoneal surface

e) Tumour implants are found on the peritoneal surface

f) The tumour thrombi present at resection margins of vessels or ureter, transected or removed piecemeal by surgeon

g) The tumour has been surgically biopsied (wedge biopsy) prior to pre-operative chemotherapy or surgery.

The presence of necrotic tumour or chemotherapy-induced changes in a lymph node or at the resection margins is regarded as proof of previous tumour with microscopic residue and therefore the tumour is assigned stage III (because of the possibility that some viable tumour is left behind in the adjacent lymph node or beyond resection margins.)

Stage IV

Haematogeneous metastases (lung, liver, bone, brain, etc.) or lymph node metastases outside the abdomino-pelvic region.

Stage V

Bilateral renal tumours at diagnosis. Each side should be sub staged according to above classifications.


Download

Click on the box below to download a PDF version of this data sheet:

Last edited: 29 December 2022 3:23 pm

  1. Cancer staging guidance sheets
  2. Lip and oral cavity (ICD10 C00, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C10-14, C30-32)
  4. Pharynx (ICD10 C01, C05.1-2, C09, C10.0, C10.2-3, C11-13)
  5. Major salivary glands (ICD10 C07, C08)
  6. Oesophagus including oesophagastric junction (ICD10 C15 & C16.0)
  7. Stomach (ICD10 C16 except C16.0)
  8. Small intestine (ICD10 C17)
  9. Appendix (ICD10 C18.1)
  10. Colon and rectum (ICD10 C18-C20)
  11. Anal canal and perianal skin data (ICD10 C21, C44.5)
  12. Liver (ICD10 C22.0)
  13. Intrahepatic bile ducts (ICD10 C22.1)
  14. Gallbladder (ICD10 C23, C24.0)
  15. Distal extrahepatic bile duct (ICD10 C24.0)
  16. Perihilar bile ducts (ICD10 C24.0)
  17. Ampulla of vater (ICD10 C24.1)
  18. Pancreas (ICD10 C25)
  19. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  20. Larynx (ICD10 C32.0 C32.1, C32.2, C10.1)
  21. Lung (ICD10 C34)
  22. Thymic tumours (ICD10 C37)
  23. Soft tissues (ICD10 C38.1-2, C47-C49)
  24. Bone (ICD10 C40 & C41)
  25. Malignant melanoma of skin (ICD10 C43, C51.0, C60.9, C63.2)
  26. Merkel cell carcinoma of skin (ICD10 C44 & C63.2)
  27. Skin carcinoma of the head and neck (ICD10 C44.0, C44.2-4)
  28. Carcinoma of skin of the eyelid (ICD10 C44.1)
  29. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  30. Pleural mesothelioma (ICD10 C45)
  31. Breast tumours (ICD10 C50)
  32. Vulva (ICD10 C51)
  33. Cervix uteri (ICD10 C53)
  34. Uterine sarcomas
  35. Uterus - endometrium (ICD10 C54.1, C55)
  36. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  37. Gestational trophoblastic neoplasms (ICD10 C58)
  38. Penis tumours (ICD10 C60)
  39. Prostate tumours (ICD10 C61)
  40. Testis tumours (ICD10 C62)
  41. Kidney tumours (ICD10 C64)
  42. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  43. Urinary bladder tumours (ICD10 C67)
  44. Urethra tumours (ICD10 C68.0)
  45. Carcinoma of conjuctiva (ICD10 C69.0)
  46. Malignant melanoma of conjuctiva (ICD10 C69.0)
  47. Retinoblastoma (ICD10 C69.2)
  48. Malignant melanoma of uvea (ICD10 C69.3, C69.4)
  49. Carcinoma of lacrimal gland (ICD10 C69.5)
  50. Sarcoma of orbit (ICD10 C69.6)
  51. Thyroid gland (ICD10 C73)
  52. Adrenal cortex (ICD10 C74.0)
  53. Chronic lymphocytic leukaemia
  54. Hepatoblastoma (CTYA)
  55. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  56. Medulloblastoma
  57. Multiple myeloma
  58. Neuroblastoma
  59. Neuroendocrine tumours of the foregut
  60. Neuroendocrine tumours of the midgut and hindgut
  61. Non-hodgkin lymphoma (children)
  62. Rhabdomyosarcoma and other soft tissue sarcomas (CTYA)
  63. Wilms tumour of the kidney